Document:

Personal Services Agreement

 Exhibit 10.41 
 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 
 Personal Services Agreement 
 By and
Between Stephan R. Targan, MD and 
 Prometheus Laboratories Inc. 
 This Agreement (the “Agreement”) is effective as of the 15th day of July, 2009 (the “Effective Date”) by and between Stephan R. Targan, MD with offices at 240 22nd Street, Santa Monica, CA 90402 (hereinafter referred to as the “Consultant”), and
Prometheus Laboratories Inc., with offices at 9410 Carroll Park Drive, San Diego, CA 92121-5201 (hereinafter referred to as “Company” or “Prometheus”). 
 This Agreement will set forth the general terms of our agreement whereby Consultant will provide to the Company the consulting services, including
speaking engagements, as described on Exhibit A hereto (the “Consulting Services”). 
 1. Engagement. Company hereby
engages Consultant to provide personal consulting services to the Company as described in Exhibit A on a part-time basis. This Agreement covers all of the services to be furnished by Consultant to Company and the parties acknowledge that there is
not now, and during the term of this Agreement shall not be, any other contract or agreement between Company and Consultant. Nothing in this Agreement shall limit Consultant’s right to provide services to any other businesses or institutions
except as provided in paragraph 5 below. 
 2. Compensation. In consideration for the Consulting Services, the Company will pay
the Consultant the fees as specified in Exhibit A. Such fees shall be paid within thirty (30) days following the performance of services upon satisfactory evidence of the provision of such Consulting Services. Consultant shall provide a
detailed statement of Consulting Services provided in the form set out in Exhibit B attached hereto no later than the tenth (10th) day of each month for Consulting Services provided by Consultant during the immediately preceding month.

 3. Expenses. The Company will reimburse Consultant for all reasonable travel and other expenses directly related to
Consultant’s performance under this Agreement provided that (a) such expenses in excess of $1,500 dollars have been approved in writing, in advance of being incurred, by an officer of the Company and (b) such expenses are of a nature
(and adequate documentary evidence has been provided) qualifying them as proper deductions on federal and state income tax returns of the Company. 
 4. Term and Termination. This Agreement shall commence on the Effective Date and shall continue in full force and effect until July 14, 2010 (the “Term”) unless earlier terminated. Either party may
terminate this Agreement at any time for any reason by providing thirty (30) days advance written notice to the other party. This Agreement 

 
may be extended by written agreement of the authorized representatives of the parties for additional one (1) year terms. If this Agreement is terminated
prior to the expiration of the initial Term or any subsequent one year terms, the parties shall not re-negotiate the terms of this Agreement or enter into a new agreement for the Services or any other consulting work until the expiration of the
initial Term or other applicable additional one year terms. In the event of a material breach of the Agreement by either party, the other party may terminate this Agreement upon providing the breaching party with written notice of the breach and ten
(10) days prior written notice of termination, provided that if the breaching party cures said breach within ten (10) days, this Agreement shall continue in full force and effect. 
 5. Absence of Conflicts. Consultant represents and warrants that Consultant is not under any existing obligation that is inconsistent with
this Agreement or that would restrict or conflict with the performance of Consultant’s obligations under this Agreement. Consultant agrees not to enter into any agreement or arrangement during the term of this Agreement that would impose on
Consultant any obligation inconsistent with this Agreement or that would restrict or conflict with the performance of Consultant’s obligations under this Agreement. If Consultant is required by any applicable guidelines or policies to make any
disclosure or take any action that conflicts with any obligations of Consultant under this Agreement or is contrary to the terms of this Agreement, Consultant shall promptly notify the Company of such obligation, specifying the nature of such
disclosure or action and identifying the applicable guideline or policy under which disclosure or action is required, prior to making such disclosure or taking such action. 
 6. Intellectual Property. All inventions or discoveries, whether or not patentable, which may arise from the Consulting Services shall be
owned exclusively by Company. Consultant agrees to cooperate in the preparation and execution of documents necessary to effect any patent or other filings deemed necessary or appropriate by the Company relating to such inventions and discoveries.

 7. Notification of Events. In addition to the obligations under paragraph 22 hereunder, Consultant shall notify Company in
writing within twenty-four (24) hours after the occurrence of any one or more of the following events: 
 (a) Consultant becomes the
subject of, or otherwise materially involved in, any government investigation of Consultant’s business practices or the provision of professional services, including being served with a search warrant in connection with such activities;

 (b) Consultant becomes the subject of any suit, action or other legal proceeding arising out of Consultant’s professional services;

 (c) Consultant becomes the subject of any disciplinary proceeding or action before any state’s medical board or similar agency
responsible for professional standards or behavior; or 
  

 2 

 (d) any act of nature or any other event occurs which has a material adverse effect on Consultant’s
ability to provide the Consulting Services. 
 8. Independent Contractor Status. The parties agree that Consultant is serving
as an independent contractor and is not an employee of the Company. As such, Consultant acknowledges that Consultant is not entitled to any medical benefits, paid time off, tax withholding or other benefits routinely provided to employees.

 9. Taxes. By reason of Consultant’s status as an independent contractor and the representations made herein, Consultant
hereby instructs the Company not to withhold any taxes from the fees paid to Consultant. Consultant acknowledges and agrees that Consultant is solely responsible for the payment of any and all domestic or foreign taxes and/or assessments imposed on
account of the payment of fees or other compensation by the Company to Consultant. Consultant expressly agrees to treat any fees and other compensation earned under this Agreement as self-employment income for federal and state income taxes,
unemployment insurance taxes, disability insurance taxes or any other taxes when such amounts become due and payable. 
 10.
Confidentiality. Consultant, during the term of this Agreement, will have access to and become acquainted with various business, technical, and financial information and compilations of information and records of the Company, all of which
shall be deemed Confidential Information (hereinafter “Confidential Information”) of the Company. Consultant shall hold such Confidential Information in strict confidence and shall not disclose any of the aforementioned Confidential
Information, directly or indirectly, or use it in any way, either during the term of this Agreement or at any time thereafter for a period of ten (10) years. All files, documents, records, and similar items, relating to the foregoing, whether
prepared by the Consultant or otherwise coming into the Consultant’s possession, shall remain the Confidential Information of the Company. Consultant shall either return to the Company, or certify to the Company, the destruction of all
Confidential Information of the Company at the termination of the Agreement. 
 11. Compliance of Laws. Consultant shall comply
in all material respects with all applicable laws, ordinances, codes and regulations of federal, state and local governments applicable to the Consulting Services provided under this Agreement. 
 12. Indemnity. Consultant agrees to indemnify and defend Company from all claims, charges, damages, and judgments arising from the breach
of Consultant’s obligations under this Agreement or the services provided by Consultant hereunder. 
 13. Limitation on
Authority. Consultant shall not have any authority to obligate or bind the Company to any agreement, purchase or obligation of any kind without the express written approval of an officer of the Company. 
 14. Assignment of Rights and Duties. The Consultant may not assign his rights or duties under this Agreement without prior written consent
of the Company, which consent may be withheld for any reason. Any attempted assignment, transfer, conveyance, or other disposition of the Consultant’s interest in this Agreement shall be void. 
  

 3 

 15. Notice. All notices and other communications required or permitted under this Agreement
shall be in writing and shall be deemed given upon personal delivery, facsimile transmission (with confirmation of receipt), delivery by a reputable overnight courier service or five (5) days following deposit in the United States mail (if sent
by certified or registered mail, postage prepaid, return receipt requested), to the parties at the following addresses (unless the party has by written notice subsequently provided a new contact person or address): 
  

			
	 For the CONSULTANT:
	  	 Stephan R. Targan, M.D.
 240 22nd Street
 Santa Monica, CA 90402

		
	 For COMPANY:
	  	 Ron Rocca
 General Manager, GI Products
 Prometheus Laboratories Inc.
 9410 Carroll Park Drive
 San Diego, CA 92121-5201

	
	         With a copy to:

		
		  	 Prometheus Laboratories Inc.
 Attention: Legal
Department
 9410 Carroll Park Drive
 San Diego, CA 92121-5201

 16. Legal Fee; Arbitration. The parties hereto expressly agree that in the event of
any dispute, controversy or claim by any party regarding this Agreement, the prevailing party shall be entitled to reimbursement by the other party to the proceeding of reasonable attorney’s fees and costs incurred by the prevailing party. Any
dispute, controversy or claim arising hereunder or in any way related to this Agreement shall be resolved by arbitration in the County of San Diego, State of California by JAMS-Endispute. The arbitration shall be conducted by a sole arbitrator
appointed by JAMS-Endispute (the “Arbitrator”). The Arbitrator’s decision shall be final and binding on all parties. The Arbitrator shall have no authority to award damages for emotional distress, punitive damages or equitable relief.
The parties intend that this arbitration provision be irrevocable and be construed as broadly as possible. The arbitration shall be governed by the provisions of the Arbitration Act, and judgment upon the award rendered by the Arbitrator may be
entered by any court having jurisdiction thereof. 
 17. Governing Law. This Agreement shall be governed by and construed under
the laws of the State of California without reference to principles of conflicts of laws. 
  

 4 

 18. Entire Agreement. This Agreement, including Exhibits A and B hereto, sets forth the
entire agreement and understanding among the parties as to the subject matter hereof and supersedes all prior agreements or understandings with respect to such subject matter, whether written or oral. This Agreement may not be amended or modified
except in writing signed by Consultant and a duly authorized officer of the Company. In the event of any inconsistency between the provisions of this Agreement and Exhibits A and B, the provisions of this Agreement shall govern. No waiver of any
term, provision or condition of this Agreement, whether by conduct or otherwise in any one or more instances shall be deemed to be or construed as a further or continuing waiver of any such term, provision or condition, or of any other term,
provision or condition. The invalidity or unenforceability of any term or provision of the parties with respect to the subject matter of this Agreement shall not affect the validity or enforceability of any other term or provision of this Agreement.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. 
 19. Force Majeure. Neither party shall be responsible for failure to perform under this Agreement if circumstances beyond their control,
including, but not limited to: acts of God, government authority, disaster or other emergencies make it illegal or impossible to hold an event. 
 20. Practice of Medicine. Consultant and Company acknowledge that Company is neither authorized nor qualified to engage in any activity which may be construed or deemed to constitute the practice of
medicine. To the extent that any act or service required of, or reserved to, Company in this Agreement is construed or deemed to constitute the practice of medicine, the performance of such act or service by Company shall be deemed waived or
unenforceable, unless this Agreement can be amended to comply with the law, in which case the parties shall make such amendment 
 21.
Referrals. Consultant shall be entitled to refer patients to any health care provider deemed by Consultant best qualified to deliver medical services to any particular patient. No term of this Agreement shall be construed as requiring or
inducing Consultant to refer patients to Company. Consultant’s rights under this Agreement shall not be dependent in any way on the referral of patients or business to Company by Consultant. 
 22. Disclosure Requirement. Prometheus requires any healthcare practitioner who is a member of a committee that selects formularies
or develops clinical guidelines and also serves as a speaker or commercial consultant for Prometheus to disclose to the committee the nature and existence of his/her relationship with Prometheus. This disclosure requirement extends for 2 years after
the termination of any speaker or consultant arrangement. 
 23. Representation Regarding Debarment and Felony Conviction.
Consultant represents to Company that Consultant has never been and is not currently debarred, excluded or banned from any federal healthcare program. Further, Consultant represents that Consultant has not been convicted of a felony involving
fraud or deceit. Consultant agrees to immediately notify the Company should Consultant become debarred, excluded or banned from any federal healthcare program or should Consultant be convicted of a felony involving fraud or deceit. 
  

 5 

 24. Patient Privacy and Health Information. Consultant shall comply, and shall require any
of the persons or entities performing any services under this Agreement on the Consultant’s behalf to comply, with all applicable federal and state laws and regulations governing patient privacy and confidentiality of health information,
including without limitation the federal Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) and its implementing regulations. 
 25. Company Code of Business Conduct and Ethics. By signing this Agreement, Consultant agrees to review and abide by Company’s Code of Business Conduct and Ethics (the “Code”) as posted on
its website at www.prometheuslabs.com. Consultant may request a hard copy of the Code if access to the internet is not available. 
 The foregoing is
acknowledged, understood and agreed to as evidenced by execution by the parties in the spaces below. 
  

			
	CONSULTANT:
		
	By:	 	/s/ Stephan R. Targan, M.D.
		 	Stephan R. Targan, M.D.

 Tax Payer ID Number:____________ 
  

			
	PROMETHEUS LABORATORIES INC.:
		
	By:	 	/s/ Ron Rocca
		 	 Ron Rocca
 General Manger, GI Products

 Approved by the Legal Dept. of 
 Prometheus Laboratories Inc.:__________ 
  

 6 

 EXHIBIT A 
  

	I.	Consulting 

  

	 	•	 	 Consultant shall be available to consult with Company for up to [***] hours over the term of this Agreement by providing his expertise regarding the
development of products for, and the diagnosis and treatment, of gastrointestinal diseases to the Company. 

 Compensation for these services will be $[***] per hour for actual services provided. Consultant shall provide a detailed invoice describing the exact Consulting Services performed, who requested the services, date of service, number
of hours spent providing the services and the deliverables to the Company no later than the tenth (10th) day of each month. Services will be tracked by a form attached as Exhibit B, or in a similar manner. Company will submit payment within thirty (30) days of receipt of such invoice. 
 Total compensation for all services provided under this Exhibit A shall not exceed: $30,000. 
 *** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with
respect to the omitted portions. 
  

 7 

 EXHIBIT B 
 Monthly Consulting Record for Prometheus Laboratories Inc. 
 Please use this form to record your time each time you
perform a service for Prometheus. Submit all forms at the end of the month for compensation under the terms of your Personal Services Agreement with Prometheus. 
 Consultant Name and Address: 
 Consulting Service Details 
  

											
	  	  	Day of service    	  	Duration of service    
(minutes/hours)	  	 Type of service
 (Consulting,
Speaking, Advisory  
Board)
	  	Prometheus
person(s) associated  
with service	  	 Brief overview of  
 subject matter
discussed,
 reviewed, etc.

	 1
	  	 	  	 	  	 	  	 	  	 
	 2
	  	 	  	 	  	 	  	 	  	 
	 3
	  	 	  	 	  	 	  	 	  	 
	 4
	  	 	  	 	  	 	  	 	  	 
	 5
	  	 	  	 	  	 	  	 	  	 
	 6
	  	 	  	 	  	 	  	 	  	 
	 7
	  	 	  	 	  	 	  	 	  	 
	 8
	  	 	  	 	  	 	  	 	  	 
	 9
	  	 	  	 	  	 	  	 	  	 
	 10
	  	 	  	 	  	 	  	 	  	 

  

 8Employment Agreement

 Exhibit 10.1 
 ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC. 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made as of the 1st day of June, 2009 (the “Effective Date”), by and
between Allscripts-Misys Healthcare Solutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Company”) and Eileen McPartland (“Executive”). 
 RECITALS 
 WHEREAS, commencing
on the Effective Date, Company desires to employ Executive subject to the terms and conditions of this Agreement; and 
 WHEREAS,
Executive desires to be employed by Company subject to the terms and conditions of this Agreement. 
 NOW THEREFORE, in consideration
of the foregoing premises, of the mutual agreements and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 AGREEMENT 
  

	1.	Employment. 

 Company hereby agrees to employ
Executive, and Executive hereby accepts employment, as Chief Operating Officer of Company, pursuant to the terms of this Agreement. Executive shall have the duties and responsibilities and perform such administrative and managerial services of that
position as are set forth in the bylaws of Company (the “Bylaws”) or as shall be delegated or assigned to Executive by the Chief Executive Officer and/or Executive Chairman of Company from time to time. Executive shall carry out
Executive’s responsibilities hereunder on a full-time basis for and on behalf of Company; provided that Executive shall be entitled to devote time to outside boards of directors, personal investments, civic and charitable activities, and
personal education and development, so long as such activities do not interfere with or conflict with Executive’s duties hereunder. Notwithstanding the foregoing, Executive agrees that, during the term of this Agreement, Executive shall not act
as an officer of any entity other than Company without the prior written consent of Company. 
  

	2.	Term. 

 The term of Executive’s
employment by Company under this Agreement (the “Employment Period”) shall commence on the Effective Date and shall continue in effect through October 9, 2011, unless earlier terminated as provided herein. Thereafter, unless
Company or Executive shall elect not to renew the Employment Period upon the expiration of the initial term or any renewal term, which election shall be made by providing written notice of nonrenewal to the other party at least ninety (90) days
prior to the expiration of the then current term, the Employment Period shall be extended for an additional twelve (12) months. If Company elects not to renew the Employment Period at the end of the initial term or any renewal term, such
nonrenewal shall be treated as a 

 
termination of the Employment Period and Executive’s employment without Cause by Company for the limited purpose of determining the payments and
benefits available to Executive (i.e., Executive shall be entitled to the severance/benefits set forth in Section 4.5.1). If Executive elects not to renew the Employment Period, the same shall constitute a termination of Executive’s
employment and the Employment Period by Executive without Cause, and Executive shall only be entitled to the payments and benefits set forth in Section 4.5.3. 
  

	3.	Compensation and Benefits. 

 In consideration
for the services Executive shall render under this Agreement, Company shall provide or cause to be provided to Executive the following compensation and benefits: 
 3.1 Base Salary. During the Employment Period, Company shall pay to Executive an annual base salary at a rate of $600,000 per annum, subject to all appropriate federal and state withholding taxes, which
base salary shall be payable in accordance with Company’s normal payroll practices and procedures. Executive’s base salary shall be reviewed annually prior to the beginning of each fiscal year of Company during the Employment Period by the
Board of Directors of Company (the “Board”), or a committee of the Board, and may be increased in the sole discretion of the Board, or such committee of the Board, based on Executive’s performance during the preceding Fiscal
Year. For purposes of this Agreement, the term “Fiscal Year” shall mean the fiscal year of Company. Executive’s base salary, as such base salary may be increased annually hereunder, is hereinafter referred to as the
“Base Salary.” 
 3.2 Performance Bonus. 
 3.2.1 Executive shall be eligible to receive cash bonuses in accordance with this Section 3.2 (each a “Performance Bonus”).
Payment of any Performance Bonus will be subject to the sole discretion of the Board or a committee of the Board in consultation with the Chief Executive Officer, and the amount of any such Performance Bonus will be determined by, and based upon
criteria selected by, the Board or such committee in consultation with the Chief Executive Officer. Based upon the foregoing exercise of discretion, Executive’s target Performance Bonus shall be 100% of Executive’s salary (the
“Target Performance Bonus”), but may, based on performance, exceed such amount. Performances Bonuses shall be paid according the terms of the bonus plan or program in which Executive participates from time to time. 
 3.3 Benefits. During the Employment Period and as otherwise provided hereunder, Executive shall be entitled to the following: 

3.3.1 Vacation. Executive shall be entitled to twenty (20) business days per Fiscal Year of paid vacation, such vacation time not
to be cumulative (i.e., vacation time not taken in any Fiscal Year shall not be carried forward and used in any subsequent Fiscal Year). 
 3.3.2 Participation in Benefit Plans. Executive shall be entitled to health and/or dental benefits, including immediate coverage for Executive and Executive’s eligible dependents, which are generally available to
Company’s senior executive employees and as provided by Company in accordance with its group health insurance plan coverage. In addition, Executive shall be entitled to 

  

 2 

 
participate in any profit sharing plan, retirement plan, group life insurance plan or other insurance plan or medical expense plan maintained by Company for
its senior executives generally, in accordance with the general eligibility criteria therein. 
 3.3.3 Physical Examination.
Executive shall be entitled to receive reimbursement for the cost of one general physical examination per twelve (12) month period during the term of the Agreement from a physician chosen by Executive in Executive’s reasonable discretion.

 3.3.4 Perquisites. Executive shall be entitled to such other benefits and perquisites that are generally available to
Company’s senior executive employees and as provided in accordance with Company’s plans, practices, policies and programs for senior executive employees of Company. 
 3.3.5 Indemnification. Executive shall be entitled to indemnification (including immediate advancement of all legal fees with respect to
any claim for indemnification) and directors’ and officers’ insurance coverage, to the extent made available to other senior executives, in accordance with the Bylaws and all other applicable policies and procedures of Company. 

3.4 Expenses. Company shall reimburse Executive for proper and necessary expenses incurred by Executive in the performance of
Executive’s duties under this Agreement from time to time upon Executive’s submission to Company of invoices of such expenses in reasonable detail and subject to all standard policies and procedures of Company with respect to such
expenses. 
 3.5 Stock Awards. Executive shall be eligible to participate in any applicable stock bonus, stock option, or
similar plan implemented by Company and generally available to its senior executive employees. The amount of any awards made thereunder shall be in the sole discretion of the Board or a committee of the Board. The Company intends to recommend to the
Compensation Committee of the Board that Company grant to the Executive, as soon as practicable after full execution of this Agreement, an award of Company restricted stock or restricted stock units with grant-date value of $2,000,000, which award
shall vest as follows: (a) $1,000,000 over a four-year period in accordance with Company’s customary vesting schedule, and (b) $1,000,000 over a two-year period but subject to satisfaction of performance conditions established by the
Compensation Committee of the Board. Executive acknowledges and agrees that the grant of the Company Stock Award shall be conditioned upon the establishment of a new Company stock incentive plan or an amendment that increases the number of shares of
Company common stock available for award under an existing Company stock incentive plan, and that such establishment or amendment must be approved by the shareholders of Company and Misys plc (“Parent”), in each case in accordance
with the law, rules and regulations applicable to such approvals. If, on the day prior to the first anniversary of the grant date of the Company Stock Award, the Company Stock Award has been granted and Executive has remained continuously employed
since the Effective Date, but the shareholder approval conditions described in the previous sentence have not been satisfied, the Company Stock Award (and any rights or obligations arising therefrom, or from this Section 3.5) shall be canceled
as of such day without payment or other consideration therefor except Company shall pay Executive, on the tenth day after such anniversary, a cash lump sum equal to one-quarter of the number of shares of Company common stock underlying the Company
Stock Award multiplied by the closing price per share of Company’s common stock on the business day next following such anniversary. 
  

 3 

 3.6 Payment upon a Change of Control. If a Change of Control occurs, and, prior to the
Change of Control, Company or representatives of the third party effecting the Change of Control (as applicable) do not offer Executive a Comparable Job following the Change of Control and, on or within ten (10) days following the Change of
Control, Executive terminates Executive’s employment and the Employment Period, then, so long as Executive has remained continuously employed from the Effective Date through the date of a Change of Control and subject to Section 4.7,
(i) all unvested Company equity awards held by Executive shall vest upon the Change of Control, and (ii) Company shall pay Executive, within twenty (20) days following the occurrence of the Change of Control, a cash lump sum equal to
the sum of Executive’s Base Salary and Target Performance Bonus (collectively, the “Change of Control Payment & Benefits”). For purposes of this Agreement, a “Comparable Job” shall mean employment
following the Change of Control (i) with substantially the same duties and responsibilities as were held by Executive prior to the Change of Control (excluding, for this purpose, changes following the Change of Control (x) to
Executive’s reporting responsibilities and (y) arising by reason of Company ceasing to be a public company), (ii) at the same location at which Executive provides services prior to the Change of Control or a location within fifty
(50) miles of such location and (iii) at the same or increased Base Salary and Target Performance Bonus levels as were in effect prior to the Change of Control. 
  

	4.	Termination of the Services Prior To the Expiration Date. 

 Executive’s employment hereunder and the Employment Period may be terminated at any time as follows (the effective date of such termination hereinafter referred to as the “Termination Date”):

 4.1 Termination upon Death or Disability of Executive. 
 4.1.1 Executive’s employment hereunder and the Employment Period shall terminate immediately upon the death of Executive. In such event, all
rights of Executive and/or Executive’s estate (or named beneficiary) shall cease except for the right to receive payment of the amounts set forth in Section 4.5.4 of the Agreement. 
 4.1.2 Company may terminate Executive’s employment hereunder and the Employment Period upon the disability of Executive. For purposes of this
Agreement, Executive shall be deemed to be “disabled” if Executive, as a result of illness or incapacity, shall be unable to perform substantially Executive’s required duties for a period of three (3) consecutive months or for
any aggregate period of three (3) months in any six (6) month period. In the event of a dispute as to whether Executive is disabled, Company may refer Executive to a licensed practicing physician of Company’s choice, and Executive
agrees to submit to such tests and examination as such physician shall deem appropriate to determine Executive’s capacity to perform the services required to be performed by Executive hereunder. In such event, the parties hereby agree that the
decision of such physician as to the disability of Executive’s shall be final and binding on the parties. Any termination of the Employment Period under this Section 4.1.2 shall be effected without any adverse effect on Executive’s
rights to receive benefits under any disability policy of Company, but shall not be treated as a termination without Cause. 
  

 4 

 4.2 Termination by Company for Cause. Company may terminate Executive’s employment
hereunder and the Employment Period for Cause (as defined herein) upon written notice to Executive, which termination shall be effective on the date specified by Company in such notice; provided, however, that Executive shall have a period of ten
(10) days (or such longer period not to exceed thirty (30) days as would be reasonably required for Executive to cure such action or inaction) after the receipt of the written notice from Company to cure the particular action or inaction,
to the extent a cure is possible. For purposes of this Agreement, the term “Cause” shall mean: 
 4.2.1 the willful
or grossly negligent failure by Executive to perform Executive’s duties and obligations hereunder in any material respect, other than any such failure resulting from the disability of Executive; 
 4.2.2 Executive’s conviction of a crime or offense involving the property of Company, or any crime or offense constituting a felony or
involving fraud or moral turpitude; provided that, in the event that Executive is arrested or indicted for a crime or offense related to any of the foregoing, then Company may, at its option, place Executive on paid leave of absence, pending the
final outcome of such arrest or indictment; 
 4.2.3 Executive’s violation of any law, which violation is materially and
demonstrably injurious to the operations or reputation of Company; 
 4.2.4 Executive’s material violation of any generally
recognized policy of Company or Executive’s refusal to follow the lawful directions of the Chief Executive Officer and/or Executive Chairman, or Executive’s insubordination to Executive’s supervisor; or 
 4.2.5 Executive’s failure during the Employment Period to retain the number shares of Company or Parent common stock set forth in Appendix A
for a period of more than 30 days. 
 4.3 Termination without Cause. Either party may terminate Executive’s employment and
the Employment Period without Cause upon thirty (30) days’ prior written notice to the other party. Upon termination of Executive’s employment with Company for any reason, Executive shall be deemed to have resigned from all positions
with the other members of Company and its subsidiaries (provided, that any such deemed resignations shall not affect Executive’s entitlement (if any) to severance pay and benefits hereunder). 
 4.4 Termination by Executive for Constructive Discharge. 
 4.4.1 Executive may terminate Executive’s employment and the Employment Period, in accordance with the process set forth below, a result of a Constructive Discharge. For purposes of this Agreement
“Constructive Discharge” shall mean the occurrence of any of the following after the Effective Date: 
  

	 	(i)	a failure of Company to meet its obligations in any material respect under this Agreement, including, without limitation, (x) any reduction in the Base Salary or
(y) any failure to pay the Base Salary (other than, in the case of clause (y), the inadvertent failure to pay a de minimis amount of the Base Salary, which payment is immediately made by Company upon notice from Executive);

  

 5 

	 	(ii)	a material diminution in or other substantial adverse alteration in the nature or scope of Executive’s responsibilities with Company from those in effect on the
Effective Date (excluding, for this purpose, changes following the Change of Control (x) to Executive’s reporting responsibilities and (y) arising by reason of Company ceasing to be a public company); or 

  

	 	(iii)	Executive has been asked to relocate Executive’s principal place of business to a location that is more than fifty (50) miles from Company’s offices located in
Raleigh, North Carolina. 

 4.4.2 For purposes of this Agreement, a “Change of Control” shall mean any
one of the following events following the Effective Date: 
  

	 	(i)	the date of acquisition by any person or group other than Parent or any affiliate of Parent or any subsidiary of the Company (or any employee benefit plans (or related trust)
of the Company or any of its subsidiaries or Parent) acquires beneficial ownership of securities possessing more than thirty percent (30%) of the total combined voting power of the Company’s then outstanding voting securities which
generally entitle the holder thereof to vote for the election of directors (“Voting Power”), provided, however, that no Change of Control shall be deemed to have occurred solely by reason of any such acquisition by a corporation
with respect to which, after such acquisition, more than sixty percent (60%) of the then outstanding shares of common stock of such corporation and the Voting Power of such corporation are then beneficially owned, directly or indirectly, by the
persons who were the beneficial owners of the stock and Voting Power of Company immediately before such acquisition, in substantially the same proportions as their ownership immediately before such acquisition; or 

  

	 	(ii)	the date the individuals who constitute the Board as of the Effective Date (the “Incumbent Board”) cease for any reason other than their deaths to constitute
at least a majority of the Board; provided that any individual who becomes a director after the Effective Date whose election or nomination for election by Company’s stockholders was approved by a vote of at least a majority of the directors
then comprising the Incumbent Board shall be considered, for purposes of this Section, as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office is in
connection with an actual or threatened election contest relating to the election of the directors of Company (as such terms are used in Rule 14a-11 under the 1934 Act); or 

  

 6 

	 	(iii)	Company effects (a) a merger or consolidation of Company with one or more corporations or entities, as a result of which the holders of the outstanding Voting Stock of
Company immediately prior to such merger, reorganization or consolidation hold less than 50% of the Voting Power of the surviving or resulting corporation or entity immediately after such merger or consolidation; (b) a liquidation or
dissolution of Company; or (c) a sale or other disposition of all or substantially all of the assets of Company other than to an entity of which Company owns at least 50% of the Voting Power; 

 provided, however, that in no event shall the acquisition by any person or group of the beneficial ownership of any amount of stock or voting securities of Parent
(including an acquisition by a merger, reorganization or consolidation) constitute a Change of Control. 
 4.4.3 For purposes of the
foregoing definition, the terms “beneficially owned” and “beneficial ownership” and “person” shall have the meanings ascribed to them in SEC rules 13d-5(b) under the 1934 Act, and “group” means two or
more persons acting together in such a way to be deemed a person for purposes of Section 13(d) of the 1934 Act. Further, notwithstanding anything herein to the contrary, the definition of Change of Control set forth herein shall not be broader
than the definition of “change in control event” as set forth under Section 409A of the Code, and the guidance promulgated thereunder, and if a transaction or event does not otherwise fall within such definition of change of control
event, it shall not be deemed a Change of Control for purposes of this Agreement. 
 4.4.4 In the event of a Constructive Discharge,
Executive shall have the right to terminate Executive’s employment hereunder and receive the benefits set forth in Section 4.5.1 below, upon delivery of written notice to Company no later than the close of business on the sixtieth
(60th) day following the effective date of a Constructive Discharge; provided, however, that such termination shall not be effective until the expiration of thirty (30) days after receipt by Company of such written notice if Company has
not cured such Constructive Discharge within the 30-day period. If Company so effects a cure, the Constructive Discharge notice shall be deemed rescinded and of no force or effect. Notwithstanding the foregoing, such notice and lapse of time shall
not be required with respect to any event or circumstance which is the same or substantially the same as an event or circumstance with respect to which notice and an opportunity to cure has been given within the previous six (6) months. The
effective date of a Constructive Discharge shall be the date of the Executive’s “separation from service” (within the meaning of Treas. Reg. Section 1.409A-1(h)). 
 4.5 Rights upon Termination. Upon termination of Executive’s employment and the Employment Period, the following shall apply:

 4.5.1 Termination by Company Without Cause or for Constructive Discharge. If Company terminates Executive’s employment
and the Employment Period without Cause, or if Executive terminates Executive’s employment and the Employment Period as a result of a Constructive Discharge, in each case either (x) prior to a Change of Control, or (y) after the
second anniversary 

  

 7 

 
of a Change of Control, Executive shall be entitled to receive payment of any Base Salary amounts that have accrued but have not been paid as of the
Termination Date, and the unpaid Performance Bonus, if any, with respect to the Fiscal Year preceding the Fiscal Year in which the Termination Date occurs (such Performance Bonus, if any, to be determined in the manner that it would have been
determined, and payable at the time it would have been payable, under Section 3.2 had there been no termination of the Employment Period). In addition, subject to Sections 4.5.2 and 4.7, below, Company shall, subject to Section 9.14,
be obligated to pay Executive (or provide Executive with) the following benefits as severance: 
  

	 	(i)	an amount equal to Executive’s Base Salary plus Executive’s Target Performance Bonus, payable in twelve (12) equal monthly installments commencing on the
Termination Date, such amount to be payable regardless of whether Executive obtains other employment and is compensated therefor (but only so long as Executive is not in violation of Section 5 hereof) (with the first two installments to be paid
on the sixtieth (60th) day following the Termination Date and the remaining ten (10) installments being paid on the ten following monthly anniversaries of such date); 

  

	 	(ii)	continuation of Executive’s then current enrollment (including family enrollment, if applicable) in all health and/or dental insurance benefits set forth in
Section 3.3.2 for a period of twelve (12) months following the Termination Date, with Executive’s contribution to such plans as if Executive were employed by Company, such contributions to be paid by Executive in the same period
(e.g., monthly, bi-weekly, etc.) as all other employees of Company; provided, however that Company may terminate such coverage if payment from Executive is not made within ten (10) days of the date on which Executive receives written notice
from Company that such payment is due; and provided, further, that such benefits may be discontinued earlier to the extent that Executive becomes entitled to comparable benefits from a subsequent employer; and 

  

	 	(iii)	for awards subject to the satisfaction of a performance condition, subject to the satisfaction of such performance condition and upon the satisfaction of such performance
condition, and based on the level of performance achieved), a pro-rata portion of any unvested stock option, restricted stock, restricted stock unit or other equity award granted to Executive pursuant to Section 3.5 equal shall vest, which
pro-rata portion shall be equal to (a) the number of shares of such award that would vest on the normal vesting date of such award, multiplied by (b) a fraction, the numerator of which is the number of days elapsed since the last regular
vesting date of such award (or the grant date, if no portion of such award has yet vested), and the denominator of which is the number of days between the last regular vesting date (or grant date, as the case may be) and the normal vesting date.

  

 8 

 4.5.2 Severance Upon Termination following a Change of Control. If Executive terminates
Executive’s employment and the Employment Period pursuant to Section 4.4 or Company terminates Executive’s employment pursuant to Section 4.3 within the period beginning on the date of a Change of Control and ending on the second
anniversary of the Change of Control, then Executive shall, subject to Section 4.7, be entitled to receive the benefits described in Sections 4.5.1(ii) (but not the payments described in Section 4.5.1(i)) and a lump sum amount of cash
equal to (x) the sum of (A) Executive’s Base Salary plus (B) Executive’s Target Performance Bonus minus (y) the cash portion of the Change of Control Payment & Benefits, if previously paid to Executive (or, if
clause (x) minus clause (y) would produce a negative number, then the payment pursuant to this Section 4.5.2 shall be zero). Subject to Sections 9.14, the lump sum to which Executive is entitled hereunder shall be paid on the
sixtieth (60th) day following the Termination Date. 
 4.5.3 Termination With Cause by Company or Without Constructive Discharge
by Executive. If Company terminates Executive’s employment and the Employment Period with Cause, or if Executive terminates Executive’s employment and the Employment Period other than as a result of a Constructive Discharge,
Company shall be obligated to pay Executive (i) any Base Salary amounts that have accrued but have not been paid as of the Termination Date; and (ii) subject to Section 9.14, the unpaid Performance Bonus, if any, with respect to the
Fiscal Year preceding the Fiscal Year in which the Termination Date occurs (such Performance Bonus, if any, to be determined in the manner it would have been determined, and payable at the time it would have been payable, under Section 3.2 had
there been no termination of the Employment Period). 
 4.5.4 Termination Upon Death or Disability. If Executive’s
employment and the Employment Period is terminated because of the death or disability of Executive, Company shall, subject to Section 9.14, be obligated to pay Executive or, if applicable, Executive’s estate, the following amounts:
(i) earned but unpaid Base Salary; and (ii) the unpaid Performance Bonus, if any, with respect to the Fiscal Year preceding the Fiscal Year in which the Termination Date occurs (such Performance Bonus, if any, to be determined in the
manner it would have been determined, and payable at the time it would have been payable, under Section 3.2 had there been no termination of the Employment Period). 
 4.6 Effect of Notice of Termination. Any notice of termination by Company, whether for Cause or without Cause, may specify that, during the notice period, Executive need not attend to any business on
behalf of Company. 
 4.7 Requirement of a Release; Exclusivity of Severance Payments under this Agreement. As a condition to
the receipt of the severance payments and termination benefits to be provided to Executive pursuant to this Section 4 upon termination of Executive’s employment, Executive shall execute and deliver to Company a general release of
employment claims against Company and its affiliates in a form reasonably satisfactory to Company within forty-five (45) days following the Termination Date (provided, that Executive shall not be required to release any rights under this
Agreement). In addition, the severance payments and termination 

  

 9 

 
benefits to be provided to Executive pursuant to this Section 4 upon termination of Executive’s employment shall constitute the exclusive payments
in the nature of severance or termination pay or salary continuation which shall be due to Executive upon a termination of employment and shall be in lieu of any other such payments under any severance plan, program, policy or other arrangement
which has heretofore been or shall hereafter be established by Company or any of its affiliates. 
  

	5.	Noncompetition and Confidentiality. 

 5.1
Covenant Not to Compete. During the Employment Period and for a period of one (1) year after the expiration or earlier termination of the Employment Period, Executive shall not, (i) directly or indirectly act in concert or
conspire with any person employed by Company or any of its Subsidiaries in order to engage in or prepare to engage in or to have a financial or other interest in any business which is a Direct Competitor (as defined below); or (ii) serve as an
employee, agent, partner, shareholder, director or consultant for, or in any other capacity participate, engage or have a financial or other interest in any business which is a Direct Competitor (provided, however, that notwithstanding anything to
the contrary contained in this Agreement, Executive may own up to two percent (2%) of the outstanding shares of the capital stock of a company whose securities are registered under Section 12 of the Securities Exchange Act of 1934, as
amended (the “1934 Act”). For purposes of this Agreement, the term “Direct Competitor” shall mean any person or entity engaged in the business of marketing or providing within the continental United States
prescription products or services for pharmacy benefit management products or services, including, without limitation, (i) prepackaged prescription products or services, (ii) point of care pharmacy dispensing systems, (iii) point of
care decision support software for physicians, (iv) mail service pharmacy products or services, (v) pharmaceuticals or pharmaceutical delivery systems, (vi) electronic medical record or practice management software,
(vii) homecare, home health or hospice support software, and (vii) electronic processing of healthcare transactions. 
 5.2
No Solicitation of Employees. During the Employment Period and for a period of one (1) year following the expiration or earlier termination of the Employment Period for any reason, Executive shall not, directly or indirectly, whether
for its own account or for the account of any other individual or entity, (i) employ, hire or solicit for employment, or attempt to employ, hire or solicit for employment, any Employee (as defined below), (ii) divert or attempt to divert,
directly or indirectly, or otherwise interfere in a material fashion with or circumvent the relationship of Company or any of its Subsidiaries with, any Employees, or (iii) induce or attempt to induce, directly or indirectly, any Employee to
terminate their employment or other business relationship with Company or any of its Subsidiaries. For purposes of this Section 5.2, “Employee” shall mean any person who is or was employed by Company or any of its Subsidiaries
during the Employment Period; provided, however, that “Employee” shall not include any person (a) whose employment with Company or a Subsidiary of Company was terminated by Company or such Subsidiary without cause, or
(b) who was not employed by Company or any of its Subsidiaries at any time during the six (6) month period immediately prior to the Termination Date. 
 5.3 Confidential Information. Company has advised Executive, and Executive acknowledges, that it is the policy of Company to maintain as secret and confidential all Protected Information (as defined
below), and that Protected Information has been and will 

  

 10 

 
be developed at substantial cost and effort to Company and its Subsidiaries. Executive shall not at any time, directly or indirectly divulge, furnish or make
accessible to any person, firm, corporation, association or other entity (otherwise than as may be required in the regular course of Executive’s employment), nor use in any manner, either during the Employment Period or after the termination of
the Employment Period for any reason, any Protected Information, or cause any such information of Company or any of its Subsidiaries to enter the public domain, except as required by law or court order. “Protected Information” means
trade secrets, confidential and proprietary business information of Company, and any other information of Company or any of its Subsidiaries, including, without limitation, customer lists (including potential customers), sources of supply,
processes, plans, materials, pricing information, internal memoranda, marketing plans, internal policies, and products and services which may be developed from time to time by Company or any of its Subsidiaries and the agents or employees of any of
them, including Executive; provided, however, that information that is in the public domain (other than as a result of a breach of this Agreement), approved for release by Company or a Subsidiary (as applicable) or lawfully obtained from third
parties who are not bound by a confidentiality agreement with Company or any of its Subsidiaries, is not Protected Information. 
 5.4
Injunctive Relief. Executive acknowledges and agrees that the restrictions imposed upon him by this Section 5 and the purpose for such restrictions are reasonable and are designed to protect the Protected Information and the
continued success of Company without unduly restricting Executive’s future employment by others. Furthermore, Executive acknowledges that in view of the Protected Information of Company and its Subsidiaries which Executive has or will acquire
or has or will have access to and the necessity of the restriction contained in this Section 5, any violation of the provisions of this Section 5 would cause irreparable injury to Company and its successors in interest with respect to the
resulting disruption in their operations. By reason of the foregoing, Executive consents and agrees that if Executive violates any of the provisions of this Section 5, Company and its successors in interest, as the case may be, shall be
entitled, in addition to any other remedies that they may have, including monetary damages, to an injunction to be issued by a court of competent jurisdiction, restraining Executive from committing or continuing any violation of this Section 5.

  

	6.	Certain Additional Payments by Company. 

 Company agrees that: 
 6.1 Anything in this Agreement to the contrary notwithstanding, in the event it shall be determined
that any payment or distribution by Company to or for the benefit of Executive (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, but determined without regard to any additional payments
required under this Section 6) (a “Payment”) would be subject to the excise tax imposed by Section 4999 of the Code or if any interest or penalties are incurred by Executive with respect to such excise tax (such excise
tax, together with any such interest and penalties, being hereafter collectively referred to as the “Excise Tax”), then Executive shall be entitled to receive an additional payment (a “Gross-Up Payment”) in an
amount such that after payment by Executive of all taxes (including interest or penalties imposed with respect to such taxes), including, without limitation, any income taxes (and any interest and penalties imposed with respect thereto) and Excise
Tax imposed upon the Gross-Up Payment, Executive retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payment. 
  

 11 

 6.2 Subject to the provisions of Section 6.3, below, all determinations required to be made
under this Section 6, including whether and when a Gross-Up Payment is required and the amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such determination, shall be made by the accounting firm which is then
serving as the auditors for Company (the “Accounting Firm”), which shall provide detailed supporting calculations both to Company and Executive within fifteen (15) business days of the receipt of notice from Executive that
there has been a Payment, or such earlier time as is requested by Company. In the event that the Accounting Firm is serving as accountant or auditor for the individual, entity, or group effecting the Change of Control, Executive shall appoint
another nationally recognized accounting firm to make the determinations required hereunder (which accounting firm shall then be referred to as the Accounting Firm hereunder). All fees and expenses of the Accounting Firm shall be borne solely by
Company. Any Gross-Up Payment, as determined pursuant to this Section 6, shall be paid by Company to Executive (or to the applicable taxing authority on Executive’s behalf) within five (5) days of the receipt of the Accounting
Firm’s determination or, if later, on the due date for such taxes. If the Accounting Firm determines that no Excise Tax is payable by Executive, it shall furnish Executive with a written opinion that failure to report the Excise Tax on
Executive’s applicable federal income tax return would not result in the imposition of a negligence or similar penalty. Any good faith determination by the Accounting Firm shall be binding upon Company and Executive. As a result of the
uncertainty in the application of Section 4999 of the Code at the time of the initial determination by the Accounting Firm hereunder, it is possible that Gross-Up Payments which will not have been made by Company should have been made
(“Underpayment”), consistent with the calculations required to be made hereunder. In the event that Company exhausts its remedies pursuant to Section 6.3, below, and Executive thereafter is required to make a payment of any
Excise Tax, the Accounting Firm shall determine the amount of the Underpayment that has occurred and any such Underpayment shall be promptly paid by Company to or for the benefit of Executive. 
 6.3 Executive shall notify Company in writing of any claim by the Internal Revenue Service that, if successful, would require the payment by
Company of a Gross-Up Payment. Such notification shall be given as soon as practicable but no later than fifteen (15) business days after Executive is informed in writing of such claim and shall apprise Company of the nature of such claim and
the date on which such claim is requested to be paid. Executive shall not pay such claim prior to the expiration of the thirty (30) day period following the date on which Executive gives such notice to Company (or such shorter period ending on
the date that any payment of taxes with respect to such claim is due). If Company notifies Executive in writing prior to the expiration of such period that it desires to contest such claim, Executive shall: 
 6.3.1 Give Company any information reasonably requested by Company relating to such claim; 
 6.3.2 Take such action in connection with contesting such claim as Company shall reasonably request in writing from time to time, including,
without limitation, accepting legal representation with respect to such claim by an attorney reasonably selected by Company; 
  

 12 

 6.3.3 Cooperate with Company in good faith in order effectively to contest such claim; and

 6.3.4 Permit Company to participate in any proceedings relating to such claim; provided, however, that Company shall bear and pay
directly all costs and expenses (including additional interest and penalties) incurred in connection with such contest and shall indemnify and hold Executive harmless, on an after-tax basis, for any Excise Tax or income tax (including interest and
penalties with respect thereto) imposed as a result of such representation and payment of costs an expenses. Without limiting the foregoing provisions of this Section 6.3, Company shall control all proceedings taken in connection with such
contest and, at its sole option, may pursue or forego any and all administrative appeals, proceedings, hearings and conferences with the taxing authority in respect of such claim and may, at its sole option, either direct Executive to pay the tax
claimed and sue for a refund or contest the claim in any permissible manner; and Executive agrees to prosecute such contest to a determination before any administrative tribunal, in a court of initial jurisdiction and in one or more appellate
courts, as Company shall determine; provided further, however, that if Company directs Executive to pay such claim and sue for a refund, Company shall advance the amount of such payment to Executive on an interest-free basis and shall indemnify and
hold Executive harmless, on an after-tax basis, from any Excise Tax or income tax (including interest or penalties with respect thereto) imposed with respect to such advance or with respect to any imputed income with respect to such advance; and
further provided that any extension of the statute of limitations relating to payment of taxes for the taxable year of Executive with respect to which such contested amount is claimed to be due is limited solely to such contested amount.
Furthermore, Company’s control of the contest shall be limited to issues with respect to which a Gross-Up Payment would be payable hereunder and Executive shall be entitled to settle or contest, as the case may be, any other issue raised by the
Internal Revenue Service or any other taxing authority. 
 6.4 If, after the receipt by Executive of an amount advanced by Company
pursuant to Section 6.3 above, Executive becomes entitled to receive any refund with respect to such claim, Executive shall (subject to Company’s complying with the requirements of said interest paid or credited thereon, after taxes
applicable thereto) promptly pay such refund to Company. If, after the receipt by Executive of an amount advanced by Company pursuant to said Section 6.3, a determination is made that Executive shall not be entitled to any refund with respect
to such claim and Company does not notify Executive in writing of its intent to contest such denial of refund prior to the expiration of thirty (30) days after such determination, then such advance shall be forgiven and shall not be required to
be repaid; and the amount of such advance shall offset, to the extent thereof, the amount of the Gross-Up Payment required to be paid. 
 6.5 Subject to any earlier time limits set forth in this Section 6, all payments and reimbursements to which Executive is entitled under this Section 6 shall be paid to or on behalf of Executive not later than the end of
the taxable year of Executive next following the taxable year of Executive in which Executive (or Company, on Executive’s behalf) remits the related taxes (or, in the event of an audit or litigation with respect to such tax liability, not later
than the end of the taxable year of Executive next following the taxable year of Executive in which there is a final resolution of such audit or litigation (whether by reason of completion of the audit, entry of a final and non-appealable judgment,
final settlement, or otherwise)). 
  

 13 

	7.	No Set-Off or Mitigation. 

 Company’s
obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which Company may have against
Executive or others. In no event shall Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to Executive under any of the provisions of this Agreement and, except as otherwise provided
herein, such amounts shall not be reduced whether or not Executive obtains other employment. 
  

	8.	Payment of Certain Expenses. 

 Company agrees
to pay promptly as incurred and not less than on a monthly basis, to the fullest extent permitted by law, all legal fees and expenses which Executive may reasonably incur as a result of any contest by Company, Executive or others of the validity or
enforceability of, or liability under, any provision of the Agreement (including as a result of any contest initiated by Executive about the amount of any payment due pursuant to this Agreement), plus in each case interest on any delayed payment at
the applicable federal rate provided for in Section 7872(f)(2)(A) of the Code; provided, however, that Company shall not be obligated to make such payment with respect to any contest in which Company prevails over Executive, and, in such case,
Executive shall return to Company any payments previously paid to or on behalf of Executive. 
  

	9.	Indemnification. 

 To the fullest extent
permitted by law, Company shall indemnify Executive (including the advancement of expenses) for any judgments, fines, amounts paid in settlement and reasonable expenses, including attorney’s fees, incurred by Executive in connection with the
defense of any lawsuit or other claim to which Executive is made a party by reason of being an officer, director or employee of Company or any of its Subsidiaries. 
  

	10.	Miscellaneous. 

 10.1 Valid
Obligation. This Agreement has been duly authorized, executed and delivered by Company and has been duly executed and delivered by Executive and is a legal, valid and binding obligation of Company and of Executive, enforceable in accordance
with its terms. 
 10.2 No Conflicts. Executive represents and warrants that the performance by Executive of Executive’s
duties hereunder will not violate, conflict with, or result in a breach of any provision of, any agreement to which Executive is a party. 
 10.3 Applicable Law. This Agreement shall be construed in accordance with the laws of the State of Illinois, without reference to Illinois’ choice of law statutes or decisions. 
 10.4 Severability. The provisions of this Agreement shall be deemed severable, and the invalidity or unenforceability of any one or more of
the provisions hereof shall not affect the validity or enforceability of any other provision. In the event any clause of this Agreement is deemed to be invalid, the parties shall endeavor to modify that clause in a manner which carries out the
intent of the parities in executing this Agreement. 
  

 14 

 10.5 No Waiver. The waiver of a breach of any provision of this Agreement by any party
shall not be deemed or held to be a continuing waiver of such breach or a waiver of any subsequent breach of any provision of this Agreement or as nullifying the effectiveness of such provision, unless agreed to in writing by the parties.

 10.6 Notices. All demands, notices, requests, consents and other communications required or permitted under this Agreement
shall be in writing and shall be personally delivered or sent by facsimile machine (with a confirmation copy sent by one of the other methods authorized in this Section), or by commercial overnight delivery service, to the parties at the addresses
set forth below: 
  

			
	To Company:	  	 Allscripts-Misys Healthcare Solutions, Inc.
 222
Merchandise Mart Plaza
 Suite 2024
 Chicago, IL 60654

Attention: Company Secretary or General Counsel

		
	To Executive:	  	 At the address or fax number most recently
 contained in
Company’s records

 Notices shall be deemed given upon the earliest to occur of (i) receipt by the party to whom such notice is
directed, if hand delivered; (ii) if sent by facsimile machine, on the day (other than a Saturday, Sunday or legal holiday in the jurisdiction to which such notice is directed) such notice is sent if sent (as evidenced by the facsimile
confirmed receipt) prior to 5:00 p.m. Central Time and, if sent after 5:00 p.m. Central Time, on the day (other than a Saturday, Sunday or legal holiday in the jurisdiction to which such notice is directed) after which such notice is sent; or
(iii) on the first business day (other than a Saturday, Sunday or legal holiday in the jurisdiction to which such notice is directed) following the day the same is deposited with the commercial carrier if sent by commercial overnight delivery
service. Each party, by notice duly given in accordance therewith may specify a different address for the giving of any notice hereunder. 
 10.7 Assignment of Agreement. This Agreement shall be binding upon and inure to the benefit of Executive and Company, their respective successors and permitted assigns and Executive’s heirs and personal representatives.
Neither party may assign any rights or obligations hereunder to any person or entity without the prior written consent of the other party. This Agreement shall be personal to Executive for all purposes. 
 10.8 Entire Agreement; Amendments. Except as otherwise provided herein, this Agreement contains the entire understanding between the
parties, and there are no other agreements or understandings between the parties with respect to Executive’s employment by Company and Executive’s obligations thereto. Executive acknowledges that Executive is not relying upon any
representations or warranties concerning Executive’s employment by Company except as expressly set forth herein. No amendment or modification to the Agreement shall be valid except by a subsequent written instrument executed by the parties
hereto. 
  

 15 

 10.9 Dispute Resolution and Arbitration. The following procedures shall be used in the
resolution of disputes: 
 10.9.1 Dispute. In the event of any dispute or disagreement between the parties under this Agreement
(excluding an action for injunctive relief as provided in Section 5.4), the disputing party shall provide written notice to the other party that such dispute exists. The parties will then make a good faith effort to resolve the dispute or
disagreement. If the dispute is not resolved upon the expiration of fifteen (15) days from the date a party receives such notice of dispute, the entire matter shall then be submitted to arbitration as set forth in Section 10.9.2.

 10.9.2 Arbitration. If the dispute or disagreement between the parties has not been resolved in accordance with the
provisions of Section 10.9.1 above, then any such controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be settled by arbitration to be held in Chicago, Illinois, in accordance with the rules of the
American Arbitration Association then in effect. Any decision rendered herein shall be final and binding on each of the parties and judgment may be entered thereon in the appropriate state or federal court. The arbitrators shall be bound to strict
interpretation and observation of the terms of this Agreement. Company shall pay the costs of arbitration. 
 10.10 Survival.
For avoidance of doubt, the provisions of Sections 4.5, 5, 8 and 9 of this Agreement shall survive the expiration or earlier termination of the Employment Period. 
 10.11 Headings. Section headings used in this Agreement are for convenience of reference only and shall not be used to construe the meaning of any provision of this Agreement. 
 10.12 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but both of which together
shall constitute one and the same instrument. 
 10.13 Taxes. Executive shall be solely responsible for taxes imposed on
Executive by reason of any compensation and benefits provided under this Agreement and all such compensation and benefits shall be subject to applicable withholding. 
 10.14 Section 409A of the Code. It is intended that this Agreement will comply with Section 409A of the Code (and any regulations and guidelines issued thereunder) to the extent the Agreement
is subject thereto, and the Agreement shall be interpreted on a basis consistent with such intent. If an amendment of the Agreement is necessary in order for it to comply with Section 409A, the parties hereto will negotiate in good faith to
amend the Agreement in a manner that preserves the original intent of the parties to the extent reasonably possible. No action or failure by Company in good faith to act, pursuant to this Section 10.14, shall subject Company to any claim,
liability, or expense, and Company shall not have any obligation to indemnify or otherwise protect Executive from the obligation to pay any taxes pursuant to Section 409A of the Code. 
 In addition, notwithstanding any provision to the contrary in this Agreement, if Executive is deemed on the date of Executive’s “separation from service”
(within the meaning of Treas. Reg. Section 1.409A-1(h)) to be a “specified employee” (within the meaning of Treas. Reg. Section 1.409A-1(i)), then with regard to any payment that is required to be delayed pursuant to
Section 409A(a)(2)(B) 

  

 16 

 
of the Code (the “Delayed Payments”), such payment shall not be made prior to the earlier of (i) the expiration of the six
(6) month period measured from the date of Executive’s “separation from service” and (ii) the date of Executive’s death. Any payments due under this Agreement other than the Delayed Payments shall be paid in accordance
with the normal payment dates specified herein. In no case will the delay of any of the Delayed Payments by Company constitute a breach of Company’s obligations under this Agreement. For all purposes under this Agreement, reference to
Executive’s “termination of employment” (and corollary terms) with Company shall be construed to refer to Executive’s “separation from service” (as determined under Treas. Reg. Section 1.409A-1(h), as uniformly
applied by Company) with Company. 
 In addition, to the extent that any reimbursement, fringe benefit or other, similar plan or arrangement in which
Executive participates during the term of Executive’s employment under this Agreement or thereafter provides for a “deferral of compensation” within the meaning of Section 409A of the Code, (i) the amount eligible for
reimbursement or payment under such plan or arrangement in one calendar year may not affect the amount eligible for reimbursement or payment in any other calendar year (except that a plan providing medical or health benefits may impose a generally
applicable limit on the amount that may be reimbursed or paid), and (ii) subject to any shorter time periods provided herein, any reimbursement or payment of an expense under such plan or arrangement must be made on or before the last day of
the calendar year following the calendar year in which the expense was incurred. 
 10.15 Payment by Subsidiaries. Executive
acknowledges and agrees that Company may satisfy its obligations to make payments to Executive under this Agreement by causing one or more of its subsidiaries to make such payments to Executive. Executive agrees that any such payment made by any
such subsidiary shall fully satisfy and discharge Company’s obligation to make such payment to Executive hereunder (but only to the extent of such payment). 
 [Signature page follows] 
  

 17 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date and year first above
written, to be effective at the Effective Date. 
  

			
	 /s/ Eileen McPartland

	Eileen McPartland
	
	ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC.
	
	 /s/ Glen Tullman

	By:	 	Glen Tullman
	Title:	 	Chairman and Chief Executive Officer

  

 18 

 Appendix A 
 Required Share Ownership 
 At all times during the Employment Period, Executive shall retain shares
of Company and/or Parent common stock with a fair market value as shown in the following schedule. For this purpose, “fair market value” shall be determined on the first day of the applicable portion of the Employment Period by reference
to the closing price of the Company common stock and/or Parent common stock on such date as reported on the principal exchange on which the Company common stock or Parent common stock, respectively, is traded. Options to purchase Company or Parent
common stock, restricted Company or Parent common stock and restricted stock units denominated in shares of Company or Parent common stock shall be included for purposes of determining whether these guidelines are satisfied, except that the fair
market value with respect to an option shall be reduced by the exercise price with respect to such option. At the Company’s reasonable request, the Executive shall provide the Company with evidence to the Company’s satisfaction that the
Executive is in compliance with these guidelines. 
  

			
	 During the following portion of the Employment Period:
	 	 Fair market value to be maintained during applicable portion of
the
Employment Period:

	From the Effective Date until the day prior to the first anniversary of the Effective Date:	 	100% of the Executive’s Base Salary on the Effective Date.
		
	From the first anniversary of the Effective Date until the day prior to the second anniversary of the Effective Date:	 	66% of the Executive’s Base Salary on the Effective Date.
		
	From the second anniversary of the Effective Date until the day prior to the third anniversary of the Effective Date:	 	33% of the Executive’s Base Salary on the Effective Date.
		
	From and after the third anniversary of the Effective Date:	 	0

  

 19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]